BB: On the contrary, it's common knowledge the AEGY dividend was not distributed to SKTO shareholders. However, I don't think it's common knowledge that the PharmaJanes agreement with SK3 Group is not consummated and therefore not binding. The information in the AEGY April 30, 2014 report was surprising. One has naturally to ask SK3 doesn't consummate its acquisitions and agreements.